Liver Metastasectomy for Metastatic Breast Cancer Patients: A Single Institution Retrospective Analysis.
hepatic surgery
liver metastases
metastatic breast cancer
personalized medicine
Journal
Journal of personalized medicine
ISSN: 2075-4426
Titre abrégé: J Pers Med
Pays: Switzerland
ID NLM: 101602269
Informations de publication
Date de publication:
08 Mar 2021
08 Mar 2021
Historique:
received:
27
12
2020
revised:
22
02
2021
accepted:
04
03
2021
entrez:
3
4
2021
pubmed:
4
4
2021
medline:
4
4
2021
Statut:
epublish
Résumé
The liver represents the first metastatic site in 5-12% of metastatic breast cancer (MBC) cases. In absence of reliable evidence, liver metastasectomy (LM) could represent a possible therapeutic option for selected MBC patients (patients) in clinical practice. A retrospective analysis including MBC patients who had undergone an LM after a multidisciplinary Tumor Board discussion at the Hepatobiliary Surgery Unit of Fondazione Policlinico Universitario "Agostino Gemelli" IRCCS in Rome, between January 1994 and December 2019 was conducted. The primary endpoint was overall survival (OS) after a MBC-LM; the secondary endpoint was the disease-free interval (DFI) after surgery. Forty-nine MBC patients underwent LM, but clinical data were only available for 22 patients. After a median follow-up of 71 months, median OS and DFI were 67 months (95% CI 45-103) and 15 months (95% CI 11-46), respectively. At univariate analysis, the presence of a negative resection margin (R0) was the only factor that statistically significantly influenced OS (78 months
Identifiants
pubmed: 33800160
pii: jpm11030187
doi: 10.3390/jpm11030187
pmc: PMC7998479
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
HPB Surg. 2014;2014:893829
pubmed: 24550602
Clin Breast Cancer. 2001 Jan;1(4):276-87
pubmed: 11899350
Eur J Surg Oncol. 2000 Mar;26(2):155-9
pubmed: 10744935
Clin Transl Oncol. 2020 Apr;22(4):512-521
pubmed: 31230220
J Am Coll Surg. 2010 May;210(5):744-52, 752-5
pubmed: 20421043
Ann Surg Oncol. 2008 Oct;15(10):2804-10
pubmed: 18670821
World J Surg. 2005 Apr;29(4):524-7
pubmed: 15770377
Breast. 2016 Dec;30:175-184
pubmed: 27764727
Surg Today. 2008;38(4):293-9
pubmed: 18368316
J Cancer Res Clin Oncol. 2013 Aug;139(8):1317-25
pubmed: 23644674
Ann Surg Oncol. 2010 Jun;17(6):1546-54
pubmed: 20143267
Am J Surg. 2006 Feb;191(2):281-3
pubmed: 16442961
Cancers (Basel). 2019 Sep 11;11(9):
pubmed: 31514362
J Breast Cancer. 2013 Jun;16(2):184-92
pubmed: 23843851
Breast Cancer Res Treat. 2016 Nov;160(1):145-152
pubmed: 27628191
CA Cancer J Clin. 2018 Jan;68(1):7-30
pubmed: 29313949
J BUON. 2013 Oct-Dec;18(4):859-65
pubmed: 24344009
Neoplasma. 2014;61(5):601-6
pubmed: 25244979
Br J Surg. 2010 Jul;97(7):1110-8
pubmed: 20632280
Eur J Surg Oncol. 2012 Oct;38(10):910-7
pubmed: 22682709
Nat Rev Clin Oncol. 2011 Jun;8(6):378-82
pubmed: 21423255
In Vivo. 2018 Sep-Oct;32(5):1247-1253
pubmed: 30150452
HPB (Oxford). 2016 Aug;18(8):700-5
pubmed: 27485066
Surgery. 2000 Apr;127(4):383-9
pubmed: 10776428
Am J Surg. 2003 Feb;185(2):158-64
pubmed: 12559448
Breast Cancer Res Treat. 2000 Jan;59(2):177-84
pubmed: 10817353
Dig Surg. 2015;32(1):52-9
pubmed: 25675843
Ann Surg. 2006 Dec;244(6):897-907; discussion 907-8
pubmed: 17122615
Surgery. 2012 May;151(5):710-6
pubmed: 22285778
Medicine (Baltimore). 2016 May;95(20):e3722
pubmed: 27196492
Ann Oncol. 2018 Aug 1;29(8):1634-1657
pubmed: 30032243
Dig Surg. 2018;35(4):372-380
pubmed: 29393171
Eur J Surg Oncol. 2013 Dec;39(12):1377-83
pubmed: 24126165
Eur J Cancer. 2018 May;95:1-10
pubmed: 29579478